Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
09/05 | Cullinan Therapeutics Insider Sold Shares Worth $1,796,676, According to a Recent SEC Filing | MT |
01/05 | Stifel Initiates Cullinan Oncology With Buy Rating, $40 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-.--% | 39.97L | |
+9.35% | 472.45Cr | |
-7.43% | 351.53Cr | |
+6.48% | 163.35Cr | |
+32.11% | 125.25Cr | |
+82.85% | 88Cr | |
+22.71% | 85Cr | |
+23.77% | 58Cr | |
-28.34% | 55Cr | |
-.--% | 15Cr |
- Stock Market
- Equities
- CGEM Stock
- News Consolidated Gems, Inc.
- Cullinan Oncology to Pay $25 Million for License Agreement With Harbour BioMed